Real-world sequential treatment patterns and outcomes in the new era of immunotherapy for advanced gastric cancer in Japan

Key Points

• This research aims to analyze the treatment patterns and outcomes of advanced gastric cancer with immunotherapy in Japan.
• Reviewed treatment patterns following nivolumab introduction
• Examined sequential therapy approaches including nivolumab and ramucirumab
• Aligned findings with Japanese Gastric Cancer Association guidelines
• Treatment patterns remained consistent with established guidelines
• Optimizing nivolumab and ramucirumab may enhance patient outcomes
• Sequential therapy shows promise for better management of advanced gastric cancer